Stockreport

Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Nautilus Biotechnology, Inc.  (NAUT) 
PDF SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platfor [Read more]